Finance
Trevi Therapeutics Inc (NASDAQ: TRVI) 41.16% Incline Turns Away Investor Interest In Company’s Stock
Trevi Therapeutics Inc (NASDAQ:TRVI) traded at $6.07 at close of the session on Monday, March 10 and made an upward move of 41.16% on its previous day’s price. Trevi Therapeutics Inc has a market cap of $542.45 million and is expected to release its quarterly
